Staging and Monitoring Response to Treatment in Primary Non-Hodgkin's Lymphoma of Bone Marrow Using 18F-Fluorodeoxyglucose Positron Emission Tomography
- 1 March 2001
- journal article
- case report
- Published by Elsevier in Clinical Lymphoma
- Vol. 1 (4) , 303-306
- https://doi.org/10.3816/clm.2001.n.006
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Hyper-CVAD Program in Burkitt's-Type Adult Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 1999
- Whole-Body Positron Emission Tomography Using18F-Fluorodeoxyglucose for Posttreatment Evaluation in Hodgkin’s Disease and Non-Hodgkin’s Lymphoma Has Higher Diagnostic and Prognostic Value Than Classical Computed Tomography Scan ImagingBlood, 1999
- MR imaging of primary lymphoma of bone: variability of T2-weighted signal intensity.American Journal of Roentgenology, 1998
- MRI appearance of primary non-Hodgkin's lymphoma of boneSkeletal Radiology, 1997
- Lymphoma: role of whole-body 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) PET in nodal staging.Radiology, 1997
- Imaging of primary multifocal osseous lymphomaSkeletal Radiology, 1997
- Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT.Radiology, 1994
- MRI in the Diagnosis of Primary Lymphoma of BoneJournal of Computer Assisted Tomography, 1992
- Primary extranodal and nodal non-Hodgkin's lymphomaEuropean Journal of Cancer and Clinical Oncology, 1989
- Occurrence and prognosis of extranodal lymphomasCancer, 1972